Alterity Therapeutics Limited (ATH.AX)
AUD 0.01
(11.11%)
AUD 0.01
(11.11%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 | 4.01 Million AUD | 2.63% |
| 2023 | 3.91 Million AUD | -23.56% |
| 2022 | 5.12 Million AUD | 18.06% |
| 2021 | 4.33 Million AUD | 0.0% |
| 2020 | - AUD | -100.0% |
| 2019 | 108.53 Thousand AUD | -46.05% |
| 2018 | 201.17 Thousand AUD | 51.95% |
| 2017 | 132.39 Thousand AUD | -7.19% |
| 2016 | 142.65 Thousand AUD | -19.33% |
| 2015 | 176.84 Thousand AUD | -51.39% |
| 2014 | 363.77 Thousand AUD | 141.12% |
| 2013 | 150.86 Thousand AUD | -19.18% |
| 2012 | 186.66 Thousand AUD | 19.55% |
| 2011 | 156.13 Thousand AUD | -27.38% |
| 2010 | 215 Thousand AUD | -49.79% |
| 2009 | 428.19 Thousand AUD | -12.97% |
| 2008 | 491.99 Thousand AUD | -2.97% |
| 2007 | 507.04 Thousand AUD | -33.5% |
| 2006 | 762.48 Thousand AUD | -71.14% |
| 2005 | 2.64 Million AUD | 14.53% |
| 2004 | 2.3 Million AUD | 27.39% |
| 2003 | 1.81 Million AUD | 127.98% |
| 2002 | 794.39 Thousand AUD | 53.9% |
| 2001 | 516.18 Thousand AUD | 555.4% |
| 2000 | 78.75 Thousand AUD | 0.0% |
| 1999 | - AUD | 0.0% |
| 1998 | - AUD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q4 | 2.11 Million AUD | 0.0% |
| 2024 FY | - AUD | -100.0% |
| 2024 Q2 | 1.9 Million AUD | 0.0% |
| 2023 FY | 3.91 Million AUD | -23.56% |
| 2023 Q4 | 1.53 Million AUD | 0.0% |
| 2023 Q2 | 2.38 Million AUD | 0.0% |
| 2022 Q4 | 2.76 Million AUD | 0.0% |
| 2022 Q2 | 2.35 Million AUD | 0.0% |
| 2022 FY | 5.12 Million AUD | 18.06% |
| 2021 FY | 4.33 Million AUD | 0.0% |
| 2021 Q4 | 2.45 Million AUD | 0.0% |
| 2021 Q2 | 1.88 Million AUD | 0.0% |
| 2020 Q1 | 927.58 Thousand AUD | -63.26% |
| 2020 FY | - AUD | -100.0% |
| 2020 Q2 | 1.85 Million AUD | 100.0% |
| 2020 Q3 | -927.58 Thousand AUD | -150.0% |
| 2020 Q4 | -1.85 Million AUD | -100.0% |
| 2019 Q3 | 1.26 Million AUD | -47.98% |
| 2019 Q1 | 1.21 Million AUD | -26.4% |
| 2019 Q4 | 2.52 Million AUD | 100.0% |
| 2019 FY | 108.53 Thousand AUD | -46.05% |
| 2019 Q2 | 2.42 Million AUD | 100.0% |
| 2018 Q3 | 824.18 Thousand AUD | -44.21% |
| 2018 Q2 | 1.47 Million AUD | 100.0% |
| 2018 FY | 201.17 Thousand AUD | 51.95% |
| 2018 Q4 | 1.64 Million AUD | 100.0% |
| 2018 Q1 | 738.7 Thousand AUD | -40.97% |
| 2017 Q1 | 951.8 Thousand AUD | -53.33% |
| 2017 Q3 | 625.72 Thousand AUD | -67.13% |
| 2017 Q2 | 1.9 Million AUD | 100.0% |
| 2017 FY | 132.39 Thousand AUD | -7.19% |
| 2017 Q4 | 1.25 Million AUD | 100.0% |
| 2016 Q4 | 2.03 Million AUD | 100.0% |
| 2016 Q2 | 2.85 Million AUD | 100.0% |
| 2016 Q3 | 1.01 Million AUD | -64.3% |
| 2016 Q1 | 1.42 Million AUD | -53.48% |
| 2016 FY | 142.65 Thousand AUD | -19.33% |
| 2015 FY | 176.84 Thousand AUD | -51.39% |
| 2015 Q2 | 3.42 Million AUD | 100.0% |
| 2015 Q3 | 1.53 Million AUD | -55.17% |
| 2015 Q4 | 3.07 Million AUD | 100.0% |
| 2015 Q1 | 1.71 Million AUD | -73.9% |
| 2014 Q2 | 1.65 Million AUD | 100.0% |
| 2014 FY | 363.77 Thousand AUD | 141.12% |
| 2014 Q3 | 3.27 Million AUD | 98.75% |
| 2014 Q1 | 825.03 Thousand AUD | -64.65% |
| 2014 Q4 | 6.55 Million AUD | 100.0% |
| 2013 Q3 | 1.16 Million AUD | -49.38% |
| 2013 Q4 | 2.33 Million AUD | 100.0% |
| 2013 Q1 | 1.15 Million AUD | 0.0% |
| 2013 FY | 150.86 Thousand AUD | -19.18% |
| 2013 Q2 | 2.3 Million AUD | 100.0% |
| 2012 FY | 186.66 Thousand AUD | 19.55% |
| 2011 FY | 156.13 Thousand AUD | -27.38% |
| 2010 FY | 215 Thousand AUD | -49.79% |
| 2009 FY | 428.19 Thousand AUD | -12.97% |
| 2008 Q1 | 127 Thousand AUD | -5.83% |
| 2008 FY | 491.99 Thousand AUD | -2.97% |
| 2008 Q4 | 119.15 Thousand AUD | 0.41% |
| 2008 Q3 | 118.66 Thousand AUD | -6.53% |
| 2008 Q2 | 126.96 Thousand AUD | -0.04% |
| 2007 FY | 507.04 Thousand AUD | -33.5% |
| 2007 Q4 | 134.86 Thousand AUD | -0.25% |
| 2007 Q3 | 135.2 Thousand AUD | 14.02% |
| 2007 Q2 | 118.58 Thousand AUD | 0.23% |
| 2007 Q1 | 118.3 Thousand AUD | -37.88% |
| 2006 Q3 | 190.67 Thousand AUD | -12.25% |
| 2006 Q2 | 217.31 Thousand AUD | 0.01% |
| 2006 Q1 | 217.29 Thousand AUD | -65.01% |
| 2006 FY | 762.48 Thousand AUD | -71.14% |
| 2006 Q4 | 190.44 Thousand AUD | -0.12% |
| 2005 Q3 | 637 Thousand AUD | -7.02% |
| 2005 Q4 | 621.08 Thousand AUD | -2.5% |
| 2005 FY | 2.64 Million AUD | 14.53% |
| 2005 Q2 | 685.06 Thousand AUD | 0.1% |
| 2005 Q1 | 684.35 Thousand AUD | 13.98% |
| 2004 Q4 | 600.43 Thousand AUD | -0.66% |
| 2004 Q1 | 561.87 Thousand AUD | -29.88% |
| 2004 FY | 2.3 Million AUD | 27.39% |
| 2004 Q3 | 604.41 Thousand AUD | 7.61% |
| 2004 Q2 | 561.68 Thousand AUD | -0.03% |
| 2003 Q4 | 801.31 Thousand AUD | 39.57% |
| 2003 Q1 | 242.4 Thousand AUD | 0.0% |
| 2003 Q2 | 263.42 Thousand AUD | 8.67% |
| 2003 FY | 1.81 Million AUD | 127.98% |
| 2003 Q3 | 574.13 Thousand AUD | 117.96% |
| 2002 FY | 794.39 Thousand AUD | 53.9% |
| 2001 FY | 516.18 Thousand AUD | 555.4% |
| 2000 FY | 78.75 Thousand AUD | 0.0% |
| 1999 FY | - AUD | 0.0% |
| 1998 FY | - AUD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| AdAlta Limited | 1.73 Million AUD | -131.286% |
| Acrux Limited | 5.09 Million AUD | 21.051% |
| Amplia Therapeutics Limited | 4.45 Million AUD | 9.735% |
| Biome Australia Limited | 13 Million AUD | 69.104% |
| BTC Health Limited | 16.36 Thousand AUD | -24467.757% |
| Chimeric Therapeutics Limited | 7.45 Million AUD | 46.105% |
| CSL Limited | 22.41 Billion AUD | 99.982% |
| Clarity Pharmaceuticals Ltd | 11.5 Million AUD | 65.07% |
| Clinuvel Pharmaceuticals Limited | 88.17 Million AUD | 95.442% |
| Noxopharm Limited | 2.4 Million AUD | -67.451% |
| PharmAust Limited | - AUD | -Infinity% |
| Proteomics International Laboratories Limited | 892.14 Thousand AUD | -350.52% |
| Prescient Therapeutics Limited | 3.71 Million AUD | -8.268% |
| PYC Therapeutics Limited | 22.05 Million AUD | 81.78% |
| Race Oncology Limited | 4 Million AUD | -0.395% |
| Starpharma Holdings Limited | 8.28 Million AUD | 51.511% |
| EZZ Life Science Holdings Limited | 66.44 Million AUD | 93.951% |
| Botanix Pharmaceuticals Limited | 601.82 Thousand AUD | -567.855% |
| Memphasys Limited | 60 Thousand AUD | -6598.808% |
| Nyrada Inc. | - AUD | -Infinity% |
| Anatara Lifesciences Ltd | - AUD | -Infinity% |
| Telix Pharmaceuticals Limited | 496.65 Million AUD | 99.191% |
| Bio-Gene Technology Limited | 18.32 Thousand AUD | -21839.329% |
| Zelira Therapeutics Limited | 94.95 Thousand AUD | -4132.965% |
| Patrys Limited | 1.39 Million AUD | -188.294% |
| Dimerix Limited | 583.47 Thousand AUD | -588.849% |
| Neuren Pharmaceuticals Limited | 231.92 Million AUD | 98.267% |
| Orthocell Limited | 5.31 Million AUD | 24.384% |
| Imugene Limited | - AUD | -Infinity% |
| Cynata Therapeutics Limited | 2.31 Million AUD | -73.571% |
| Immutep Limited | 3.5 Million AUD | -14.649% |
| Arovella Therapeutics Limited | 17 Thousand AUD | -23542.853% |
| Nanollose Limited | 12.5 Thousand AUD | -32051.708% |
| Invex Therapeutics Ltd | 1.21 Million AUD | -231.554% |
| NeuroScientific Biopharmaceuticals Limited | - AUD | -Infinity% |
| Island Pharmaceuticals Limited | 1.25 Million AUD | -221.138% |
| Biotron Limited | - AUD | -Infinity% |
| Radiopharm Theranostics Limited | 299.22 Thousand AUD | -1243.218% |
| Tissue Repair Ltd | 152.24 Thousand AUD | -2540.098% |
| AnteoTech Limited | 460.39 Thousand AUD | -773.004% |
| Hexima Limited | - AUD | -Infinity% |
| Paradigm Biopharmaceuticals Limited | 65.8 Thousand AUD | -6008.336% |
| Recce Pharmaceuticals Ltd | - AUD | -Infinity% |
| Avecho Biotechnology Limited | 473.55 Thousand AUD | -748.754% |
| Actinogen Medical Limited | 9.93 Million AUD | 59.53% |
| Immuron Limited | 4.9 Million AUD | 18.022% |
| Argenica Therapeutics Limited | 2.59 Million AUD | -54.711% |